Universal Health Services (UHS) Stock: Charts & Financials

Universal Health Services, Inc. (UHS)UHSUniversal Health Services, Inc.

About Universal Health Services, Inc.

Universal Health Services, Inc. (UHS), operating through its various divisions, is a healthcare entity that both owns and manages a network of acute care hospitals, along with outpatient and specialized behavioral health treatment centers. Its business operations are strategically bifurcated into two main segments: Acute Care Hospital Services and Behavioral Health Care Services. The hospitals under its management provide a comprehensive spectrum of medical provisions, encompassing general and specialty surgical interventions, internal medicine, obstetrics, urgent and emergency department services, diagnostic imaging (radiology), cancer therapy (oncology), advanced diagnostic procedures, cardiac care, pediatric medicine, pharmaceutical services, and mental health support. As of a reported date of February 24, 2022, the company's significant presence included the ownership or operation of 363 inpatient facilities, complemented by 40 outpatient and other specialized sites. These facilities are distributed across 39 U.S. states, the District of Columbia, the United Kingdom, and Puerto Rico. Beyond direct patient care, UHS also extends into commercial health insurance provision and offers a variety of crucial management support functions. These include centralized procurement, information technology infrastructure, financial oversight and control mechanisms, strategic facilities planning, physician talent acquisition, administrative staff management, marketing initiatives, and public relations efforts. Universal Health Services, Inc. was established in 1978 and maintains its principal executive offices in King of Prussia, Pennsylvania.

King of Prussia, PA

101,500 employees

uhs.com

Healthcare / Medical - Care Facilities

Sector: Healthcare
Industry: Medical - Care Facilities
CEO: Marc D. Miller

View full financials

Quarterly Report	TTM	Quarter ended Jun 2026	Quarter ended Mar 2026	Quarter ended Dec 2025	Quarter ended Sep 2025	Quarter ended Jun 2025	Quarter ended Mar 2025	Quarter ended Dec 2024	Quarter ended Sep 2024
Revenue	18.11B	4.64B	4.50B	4.49B	4.50B	4.28B	4.10B	4.11B	3.96B
Cost of Goods Sold	1.69B	423.26M	426.54M	422.76M	414.58M	418.79M	402.88M	405.90M	390.25M
Gross Profit	16.43B	4.21B	4.07B	4.06B	4.08B	3.87B	3.70B	3.71B	3.57B
Gross Profit Margin	90.7%	90.9%	90.5%	90.6%	90.8%	90.2%	90.2%	90.1%	90.2%
Total Operating Expenses	14.37B	3.70B	3.57B	3.55B	3.56B	3.36B	3.24B	3.24B	3.19B
Research & Development	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Selling, General & Administrative	8.46B	2.14B	2.13B	2.09B	2.11B	2.05B	1.99B	1.95B	1.95B
Operating Income (EBIT)	2.06B	516.67M	502.86M	517.23M	521.69M	500.27M	454.82M	472.49M	384.17M
Operating Margin	11.4%	11.1%	11.2%	11.5%	11.6%	11.7%	11.1%	11.5%	9.7%
Income Before Tax (EBT)	2.03B	479.13M	469.12M	581.44M	496.89M	473.38M	420.43M	438.31M	341.53M
Interest Income	524K	N/A	91K	247K	186K	349K	407K	389K	368K
Interest Expense	155.72M	39.91M	35.97M	42.46M	37.37M	34.46M	40.46M	40.11M	45.03M
Other Income/Expense	-31.89M	-37.55M	-33.74M	64.21M	-24.80M	-26.89M	-34.40M	-34.18M	-42.63M
Net Income	1.53B	358.45M	348.68M	445.94M	372.96M	353.22M	316.68M	332.40M	258.71M
Income Tax Expense	476.36M	114.54M	110.44M	133.60M	117.78M	110.77M	98.80M	101.26M	75.62M
Net Profit Margin	8.4%	7.7%	7.8%	9.9%	8.3%	8.2%	7.7%	8.1%	6.5%
EBITDA	2.70B	684.01M	658.29M	680.57M	676.75M	652.27M	603.17M	619.27M	533.73M
EBITDA Margin	14.9%	14.7%	14.6%	15.2%	15.1%	15.2%	14.7%	15.1%	13.5%
Depreciation & Amortization	641.16M	167.34M	155.43M	163.33M	155.06M	152.00M	148.34M	146.78M	149.57M
EPS Basic	24.66	6.01	5.71	7.14	5.80	5.49	4.87	5.07	3.89
EPS Diluted	24.38	5.98	5.65	7.01	5.74	5.43	4.80	4.96	3.80
Shares Outstanding	59.64M	59.64M	61.07M	63.58M	64.36M	64.36M	64.97M	65.60M	66.54M
Diluted Shares Outstanding	59.94M	59.94M	61.67M	64.46M	64.99M	64.99M	66.04M	67.07M	68.11M

Quarterly Report

TTM

Quarter ended Jun 2026

Quarter ended Mar 2026

Quarter ended Dec 2025

Quarter ended Sep 2025

Quarter ended Jun 2025

Quarter ended Mar 2025

Quarter ended Dec 2024

Quarter ended Sep 2024

Revenue

18.11B

4.64B

4.50B

4.49B

4.50B

4.28B

4.10B

4.11B

3.96B

Cost of Goods Sold

1.69B

423.26M

426.54M

422.76M

414.58M

418.79M

402.88M

405.90M

390.25M

Gross Profit

16.43B

4.21B

4.07B

4.06B

4.08B

3.87B

3.70B

3.71B

3.57B

Gross Profit Margin

90.7%

90.9%

90.5%

90.6%

90.8%

90.2%

90.1%

90.2%

Total Operating Expenses

14.37B

3.70B

3.57B

3.55B

3.56B

3.36B

3.24B

3.19B

Research & Development

N/A

Selling, General & Administrative

8.46B

2.14B

2.13B

2.09B

2.11B

2.05B

1.99B

1.95B

Operating Income (EBIT)

2.06B

516.67M

502.86M

517.23M

521.69M

500.27M

454.82M

472.49M

384.17M

Operating Margin

11.4%

11.1%

11.2%

11.5%

11.6%

11.7%

11.1%

11.5%

9.7%

Income Before Tax (EBT)

2.03B

479.13M

469.12M

581.44M

496.89M

473.38M

420.43M

438.31M

341.53M

Interest Income

524K

N/A

91K

247K

186K

349K

407K

389K

368K

Interest Expense

155.72M

39.91M

35.97M

42.46M

37.37M

34.46M

40.46M

40.11M

45.03M

Other Income/Expense

-31.89M

-37.55M

-33.74M

64.21M

-24.80M

-26.89M

-34.40M

-34.18M

-42.63M

Net Income

1.53B

358.45M

348.68M

445.94M

372.96M

353.22M

316.68M

332.40M

258.71M

Income Tax Expense

476.36M

114.54M

110.44M

133.60M

117.78M

110.77M

98.80M

101.26M

75.62M

Net Profit Margin

8.4%

7.7%

7.8%

9.9%

8.3%

8.2%

7.7%

8.1%

6.5%

EBITDA

2.70B

684.01M

658.29M

680.57M

676.75M

652.27M

603.17M

619.27M

533.73M

EBITDA Margin

14.9%

14.7%

14.6%

15.2%

15.1%

15.2%

14.7%

15.1%

13.5%

Depreciation & Amortization

641.16M

167.34M

155.43M

163.33M

155.06M

152.00M

148.34M

146.78M

149.57M

EPS Basic

24.66

6.01

5.71

7.14

5.80

5.49

4.87

5.07

3.89

EPS Diluted

24.38

5.98

5.65

7.01

5.74

5.43

4.80

4.96

3.80

Shares Outstanding

59.64M

61.07M

63.58M

64.36M

64.97M

65.60M

66.54M

Diluted Shares Outstanding

59.94M

61.67M

64.46M

64.99M

66.04M

67.07M

68.11M

Annual Report	12/31/2025	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019	12/31/2018
Revenue	17.36B	15.83B	14.28B	13.40B	12.64B	11.56B	11.38B	10.77B
Cost of Goods Sold	1.66B	1.59B	1.53B	1.47B	1.43B	1.29B	1.25B	1.17B
Gross Profit	15.71B	14.24B	12.75B	11.93B	11.21B	10.27B	10.13B	9.60B
Gross Profit Margin	90.4%	90.0%	89.3%	89.0%	88.7%	88.9%	89.0%	89.2%
Total Operating Expenses	13.71B	12.56B	11.57B	10.92B	9.85B	8.91B	8.91B	8.43B
Research & Development	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Selling, General & Administrative	8.23B	7.67B	7.25B	6.89B	6.28B	5.73B	5.70B	5.36B
Operating Income (EBIT)	1.99B	1.68B	1.18B	1.00B	1.36B	1.36B	1.22B	1.18B
Operating Margin	11.5%	10.6%	8.2%	7.5%	10.8%	11.8%	10.7%	10.9%
Income Before Tax (EBT)	1.97B	1.50B	940.43M	866.26M	1.29B	1.25B	1.07B	1.03B
Interest Income	1.19M	1.43M	572K	378K	1.60M	2.80M	N/A	N/A
Interest Expense	157.26M	187.53M	207.25M	127.27M	85.27M	109.09M	162.73M	154.96M
Other Income/Expense	-21.87M	-183.88M	-234.96M	-137.29M	-69.78M	-106.27M	-149.57M	-140.74M
Net Income	1.49B	1.14B	717.79M	675.61M	991.59M	943.95M	814.85M	779.71M
Income Tax Expense	460.96M	334.83M	221.12M	209.28M	305.68M	299.29M	238.79M	236.64M
Net Profit Margin	8.6%	7.2%	5.0%	5.0%	7.8%	8.2%	7.2%	7.2%
EBITDA	2.61B	2.27B	1.74B	1.59B	1.90B	1.87B	1.71B	1.63B
EBITDA Margin	15.0%	14.3%	12.2%	11.8%	15.0%	16.2%	15.0%	15.1%
Depreciation & Amortization	618.74M	584.83M	568.04M	581.86M	533.21M	510.49M	490.39M	453.05M
EPS Basic	23.42	17.16	10.35	9.23	11.99	11.06	9.16	8.36
EPS Diluted	23.10	16.82	10.23	9.14	11.82	10.99	9.13	8.32
Shares Outstanding	63.58M	66.55M	69.32M	73.12M	82.52M	85.06M	88.76M	93.28M
Diluted Shares Outstanding	64.46M	67.90M	70.13M	73.83M	83.69M	85.59M	89.04M	93.75M

Annual Report

12/31/2025

12/31/2024

12/31/2023

12/31/2022

12/31/2021

12/31/2020

12/31/2019

12/31/2018

Revenue

17.36B

15.83B

14.28B

13.40B

12.64B

11.56B

11.38B

10.77B

Cost of Goods Sold

1.66B

1.59B

1.53B

1.47B

1.43B

1.29B

1.25B

1.17B

Gross Profit

15.71B

14.24B

12.75B

11.93B

11.21B

10.27B

10.13B

9.60B

Gross Profit Margin

90.4%

90.0%

89.3%

89.0%

88.7%

88.9%

89.0%

89.2%

Total Operating Expenses

13.71B

12.56B

11.57B

10.92B

9.85B

8.91B

8.43B

Research & Development

N/A

Selling, General & Administrative

8.23B

7.67B

7.25B

6.89B

6.28B

5.73B

5.70B

5.36B

Operating Income (EBIT)

1.99B

1.68B

1.18B

1.00B

1.36B

1.22B

1.18B

Operating Margin

11.5%

10.6%

8.2%

7.5%

10.8%

11.8%

10.7%

10.9%

Income Before Tax (EBT)

1.97B

1.50B

940.43M

866.26M

1.29B

1.25B

1.07B

1.03B

Interest Income

1.19M

1.43M

572K

378K

1.60M

2.80M

N/A

Interest Expense

157.26M

187.53M

207.25M

127.27M

85.27M

109.09M

162.73M

154.96M

Other Income/Expense

-21.87M

-183.88M

-234.96M

-137.29M

-69.78M

-106.27M

-149.57M

-140.74M

Net Income

1.49B

1.14B

717.79M

675.61M

991.59M

943.95M

814.85M

779.71M

Income Tax Expense

460.96M

334.83M

221.12M

209.28M

305.68M

299.29M

238.79M

236.64M

Net Profit Margin

8.6%

7.2%

5.0%

7.8%

8.2%

7.2%

EBITDA

2.61B

2.27B

1.74B

1.59B

1.90B

1.87B

1.71B

1.63B

EBITDA Margin

15.0%

14.3%

12.2%

11.8%

15.0%

16.2%

15.0%

15.1%

Depreciation & Amortization

618.74M

584.83M

568.04M

581.86M

533.21M

510.49M

490.39M

453.05M

EPS Basic

23.42

17.16

10.35

9.23

11.99

11.06

9.16

8.36

EPS Diluted

23.10

16.82

10.23

9.14

11.82

10.99

9.13

8.32

Shares Outstanding

63.58M

66.55M

69.32M

73.12M

82.52M

85.06M

88.76M

93.28M

Diluted Shares Outstanding

64.46M

67.90M

70.13M

73.83M

83.69M

85.59M

89.04M

93.75M

Income Statement

Quarterly Income Statement (USD)

Annual Income Statement (USD)